DXCM vs ZBH — Key Metrics
| Metric | DXCM (DEXCOM INC) | ZBH (ZIMMER BIOMET HOLDINGS INC) |
|---|---|---|
| Price | 86.29 | 88.83 |
| Market Cap | 32.56 Billion | 16.94 Billion |
| P/E (TTM) | 33.32 | 21.51 |
| P/B (Quarterly) | 10.73 | 1.483 |
| P/S (TTM) | 6.55 | 1.99 |
| Net Profit Margin (TTM) | 20.1 | 9.5 |
| Gross Margin (TTM) | 62.5 | 69.9 |
| ROE (TTM) | 36.2 | 6.4 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
DXCM · DEXCOM INC
Outperform
ZBH · ZIMMER BIOMET HOLDINGS INC
Underperform
Recommendation Summary
Stock DXCM is projected to outperform the market, stock ZBH is projected to underperform the market. Upfront Recommendation: DXCM.
Financial Metrics
Prices delayed ~15 min
| DXCM | Metrics | ZBH |
|---|---|---|
| $86.29 | Price | $88.83 |
| — | Market Capitalization | — |
| 33.32 | Price to Earnings Ratio | 21.51 |
| 6.55 | Price to Sales | 1.99 |
| 23.18 | Price to FCF Ratio | 14.12 |
| 10.49 | Price to Gross Profit | 2.85 |
| 53.91 | Price to R&D | 38.26 |
| 7.97 | Price to Current Assets | 3.32 |